Physician profile
Patience Assobmo
NPI 1124595723
$4,879.59
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $4,318 · 2023: $341 · 2024: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.60 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $4,230.77 | 2022-2024 | Nexplanon, Nuvaring |
| Astellas Pharma US INC | $195.43 | 2023-2024 | Veozah |
| Abbvie INC. | $155.37 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $53.76 | 2024 | Gemtesa |
| Amgen INC. | $52.75 | 2022-2023 | Prolia, Evenity |
| Shield Therapeutics INC | $38.54 | 2023 | Accrufer |
| Evofem Biosciences, INC. | $37.65 | 2022 | |
| Therapeuticsmd, INC. | $31.59 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $25.18 | 2023 | Eliquis |
| Exeltis, USA INC. | $22.59 | 2023 | Slynd |
| Exact Sciences Corporation | $20.96 | 2023 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patience Assobmo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.